logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • FAQ
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • News and Events
    • News
    • Events
  • Contact Us

Recent News

VGXI Official Statement Regarding COVID-19

April 17, 2020

A Message from VGXI Regarding the Coronavirus (COVID-19) Outbreak and VGXI Actions LAST UPDATED February 12, 2021 To our Valued Clients and Business Partners, VGXI recognizes your concerns regarding the potential impact of the coronavirus outbreak on our products and services. VGXI is actively monitoring the situation and will continue to provide… Read More »

VGXI Official Update Following Winter Storm Uri

February 23, 2021

To our Valued Clients and Business Partners, Thank you for everyone’s concern regarding the severe winter storm conditions that swept through Texas during the week of 15Feb21. The VGXI offices remained closed for the week to ensure the safety of all our team members as they faced challenges from icy road conditions,… Read More »

VGXI Breaks Ground for New Manufacturing Facility in Conroe, TX

November 10, 2020

Plasmid DNA Manufacturer VGXI, Inc. Breaks Ground for New Conroe-based Manufacturing Facility. The Woodlands, TX – VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, held a groundbreaking ceremony on November 10, 2020 for its new greenfield manufacturing facility. The milestone event was hosted by VGXI in accordance… Read More »

VGXI Wins Best Contract Manufacturing Organization for the 2020 Vaccine Industry Excellence Awards

October 1, 2020

Texas-based plasmid DNA CDMO VGXI, Inc. was recognized as the winner of the 2020 ViE Award for Best Contract Manufacturing Organization Award at the World Vaccine Congress Washington.

VGXI Completes Land Purchase and Advances Design Development for New Manufacturing Facility

August 6, 2020

Plasmid DNA Manufacturer VGXI, Inc. Completes Land Purchase and Proceeds with Design Development Phase for New Expanded Manufacturing Facility. The Woodlands, TX – VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has closed on the purchase of greenfield for a new, expanded manufacturing facility. The… Read More »

VGXI’s Statement on the Recent Litigation Involving Inovio Pharmaceuticals, Inc. (“Inovio”) in Pennsylvania State Court

June 4, 2020

Update June 26, 2020: VGXI and GeneOne are pleased with the court’s decision in our favor protecting our company’s intellectual property rights. We have always been willing to manufacture any vaccine candidate for Covid-19, and want to help find a cure. Original Post on June 04, 2020: VGXI was surprised by Inovio’s… Read More »

VGXI Enables Rapid GMP DNA Manufacturing Timeline for Geneos Therapeutics Personalized Cancer Immunotherapy

May 19, 2020

VGXI, Inc., Geneos Therapeutics’ CDMO partner, completes manufacturing of first GMP Lot under Clinical Manufacturing Supply Agreement. THE WOODLANDS,TX AND PLYMOUTH MEETING, PA – Leading plasmid DNA contract manufacturer VGXI, Inc. announced it has completed accelerated cGMP manufacturing of the first clinical batch of a personalized neoantigen vaccine for its client Geneos… Read More »

Deison Technology Park Provides Increased Capacity for VGXI to Manufacture Vaccines

April 24, 2020

News article released this week by the Conroe Economic Development Council announced VGXI’s planned 240,000 square-foot facility to meet increasing demand for high quality plasmid DNA products and services http://www.conroeedc.org/deison-technology-park-provides-increased-capacity-for-vgxi/

VGXI Supports Rapid Timeline to Clinical Testing for Coronavirus Vaccine

April 6, 2020

Plasmid CDMO VGXI, Inc. Completes Manufacturing and Release of a Vaccine against COVID-19 in Record-Setting Time The Woodlands, TX – VGXI, an industry leading provider of GMP grade plasmid DNA for vaccines and gene therapies, announced it has completed manufacturing and release of a DNA vaccine to combat the COVID-19 pandemic. VGXI… Read More »

VGXI Recognized as Best CMO Finalist for the 2020

March 4, 2020

Texas-based plasmid DNA manufacturer VGXI, Inc. recognized as a finalist for Best CMO for the ViE Awards of the World Vaccine Congress The Woodlands, TX – VGXI, Inc., a uniquely specialized CDMO providing high quality plasmid DNA-based products and services, announced it has been nominated as a finalist in the category of… Read More »

VGXI to Exhibit at Gene Therapy for Rare Disorders

February 27, 2020

The 4th Annual Gene Therapy for Rare Disorders will focus on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Visit VGXI at Booth #6 or meet with one of our representatives during the conference to learn more about how our plasmid manufacturing services can support your gene… Read More »

VGXI to Exhibit at the 2020 World Vaccine Congress

February 27, 2020

The World Vaccine Congress is a critical strategic partnering event for the global vaccine industry. Visit our Booth #310 or meet with a representative from VGXI during the conference in April to learn more about how our plasmid manufacturing services can support your vaccine program! Each year at WVC the winners are announced… Read More »

VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration

January 29, 2020

Texas-based plasmid DNA Manufacturer VGXI, Inc. to Enable Accelerated Production of a Vaccine against the 2019 Novel Coronavirus in a CEPI Funded Collaboration The Woodlands, TX – VGXI, a world leading contract manufacturer of clinical grade DNA plasmid, announced it will start production of a DNA vaccine against the novel coronavirus (2019-nCoV)… Read More »

  • 1
  • 2
  • 3
  • …
  • 17
  • Next »
View More

Sign Up

For more information

Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Get In Touch

We would like to hear from you. Contact us today to ask a question or request a quote for our plasmid DNA manufacturing services.

CONTACT US


logo

VGXI, INC.

2700 Research Forest Drive, Suite 180, The Woodlands, Texas 77381, USA

281-296-7300

© 2020 VGXI, Inc. All Rights Reserved. | Terms and Conditions | Privacy Policy | Resources | Careers